Tiplaxtinin, a Novel, Orally Efficacious Inhibitor of Plasminogen Activator Inhibitor-1: Design, Synthesis, and Preclinical Characterization-Reference-Cited by-同舟云学术

Tiplaxtinin, a Novel, Orally Efficacious Inhibitor of Plasminogen Activator Inhibitor-1: Design, Synthesis, and Preclinical Characterization

Published:2004-06-05 Issue:14 Volume:47 Page:3491-3494
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Elokdah Hassan¹,Abou-Gharbia Magid¹,Hennan James K.¹,McFarlane Geraldine¹,Mugford Cheryl P.¹,Krishnamurthy Girija¹,Crandall David L.¹

Affiliation:

1. Chemical and Screening Sciences, Wyeth Research, CN 8000, Princeton, New Jersey 08543, and Pearl River, New York 10965, and Cardiovascular, Metabolic Diseases; Drug Safety and Metabolism, Wyeth Research, 500 Arcola Road, Collegeville, Pennsylvania 19426

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm049766q

Reference21 articles.

1. Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries.

Cited by 145 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Specific inhibition on PAI-1 reduces the dose of Alteplase for ischemic stroke treatment;International Journal of Biological Macromolecules;2024-02

2. Directing-group-free strategy for the iodine-mediated regioselective dichalcogenation of indolines: understanding the full catalytic cycles;Organic Chemistry Frontiers;2024

3. The fibrinolysis renaissance;Journal of Thrombosis and Haemostasis;2023-12

4. Cutting Edge: Serpine1 Negatively Regulates Th1 Cell Responses in Experimental Autoimmune Encephalomyelitis;The Journal of Immunology;2023-11-01

5. Crosstalk between small-cell lung cancer cells and astrocytes mimics brain development to promote brain metastasis;Nature Cell Biology;2023-10